Delta, Kelowna, BC - June 30, 2020 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca release today's podcast edition of cannabis news and stocks to watch plus insight from thought leaders and experts.
Listen to the podcast:Investor Ideas Potcasts, Cannabis News and Stocks on the Move; Episode 435 (TSX:RIV) (TSXV: RTI) (TSXV: XLY) (NASDAQ: NEPT) (TSX: NEPT) (NYSE: ACB) (TSX: ACB)
Today's podcast overview/transcript:
Good afternoon and welcome to another episode of Investorideas.com "Potcast" featuring cannabis news, stocks to watch as well as insights from thought leaders and experts.
In today's podcast we look at a few public company announcements.
Dynaleo, the Edmonton, AB manufacturer of premium cannabis-infused gummies, has signed a letter of intent with its first international partner.
Dynaleo, part of Canopy Rivers' (TSX:RIV) (OTC:CNPOF) portfolio of disruptive cannabis companies, made the announcement a week after they received their Standard Processing License from Health Canada.
"We are pleased to have entered into a non-binding Letter of Intent with Pantry, a premium cannabis-infused food brand. This agreement complements our already existing relationships with cannabis brands in Canada," says Michael Krestell, Executive Chairman.
"Pantry's focus on quality products made with natural ingredients fits perfectly with our own commitment to manufacturing gummies that are of the highest quality," he adds.
Based in Los Angeles, California, Pantry was created by a group of award-winning chefs and offers a variety of cannabis-infused food products. This is the brand's first foray into Canada.
According to the agreement, Dynaleo will manufacture and distribute cannabis-infused vegan gummies under the Pantry brand within the Canadian market.
"Pantry is excited to combine our passion for creating delicious health conscious cannabis products with Dynaleo's operational excellence. Dynaleo's facility and their state-of-the-art equipment will help us achieve best-in-class efficiencies in the market. More importantly, the Dynaleo team is what really inspired us. We are a people and culture driven organization and we couldn't be more impressed with Michael Krestell, Tom Vella and the whole Dynaleo team", says Scott Jennings, CEO and Co-Founder of Pantry.
Production on the Pantry-branded vegan gummies is expected to begin in later this year at Dynaleo's state of the art, 27,000 square-foot facility, the first industrial-scale and purpose-built high-volume cannabis edible factory in Canada.
"Dynaleo is committed to providing innovative gummy solutions for our partners. We are uniquely positioned, because of the proprietary nature of our high-volume factory, to meet consumer demand for gummies in Canada," says Krestell.
Solid edible products, led by gummies, currently comprise more than 90% of the top-selling infused products. Deloitte estimates that Canada's edibles market is worth $1.6 billion annually, while Arcview Market Research and BDS Analytics predict that the North American edibles market will be worth more than $4.1 billion by 2022. A new report from the market research firm Headset also shows an uptick in gummy purchases in several jurisdictions since the beginning of the COVID-19 pandemic.
Radient Technologies Inc. (TSXV: RTI) (OTCQX: RDDTF), a manufacturer of high quality cannabinoid-based formulations and products, has received a Health Canada license amendment for the sale of cannabis extracts, cannabis edibles and cannabis topicals. This license, which allows for the sale of all three categories of extracted products, is a significant milestone in commercializing the Company's product offerings and launching its 2.0 product portfolio. Radient is also pleased to announce that it has entered into a manufacturing and service agreement with Premium 5 Ltd. ("P5") for multiple products under its brand of premium concentrates.
"Receiving this license amendment is a critical step in diversifying and evolving Radient's business model through new products and customers," said Denis Taschuk, Chief Executive Officer, Radient Technologies. "The sales license will give Radient the ability to leverage our unique formulations for exciting new consumer products."
In anticipation of receiving its sales license, Radient has started the process of increasing its product manufacturing and filling capabilities. The Company will have substantial capacity for white label production of unique 2.0 products that uses its extensive formulation library. Radient believes this will be a significant advantage in signing further manufacturing agreements and capturing new revenue opportunities. Over the coming month, Radient looks forward to updating stakeholders and customers on innovative offerings.
The partnership with P5, Canada's preeminent concentrate supplier, will involve multiple new product lines, bringing P5 concentrates to market with final manufacturing completed by Radient. Under the renewable one-year agreement, Radient will supply distillate, and provide manufacturing services for a minimum of 240,000 units. The first products planned will be a live resin vape cartridge, along with a live resin X cartridge that will be blended with Radient's THC distillate.
Premium 5 is Canada's leader in bringing quality concentrate products and curated devices to market. P5 launched the first live resin concentrates in the country and has quickly become synonymous with the highest levels of quality and cutting-edge products.
Auxly Cannabis Group Inc. (TSXV: XLY) , a consumer packaged goods company in the cannabis products market, announced that its wholly owned subsidiary, Dosecann LD Inc. has received its Cannabis Research Licence from Health Canada pursuant to the Cannabis Act. This licence permits Dosecann to administer cannabis extracts, edible cannabis and cannabis topicals to human subjects for purposes of palatability and sensory testing at its state-of-the-art facility located in Charlottetown, Prince Edward Island.
Dosecann has spent the last few years developing highly accurate, proprietary processes in order to create the Company's first-class suite of cannabis products, however, due to regulatory restrictions, the product development team was unable to fully evaluate the impact of cannabis infusion on the taste of its edible products. With this licence, Dosecann can now conduct broader in-house testing, incorporating consumer input and feedback on attributes such as flavour, aroma, texture or mouthfeel, to better evaluate later-stage product formulations.
"Up until now, our team of product developers at Dosecann knew we had great tasting non-infused formulations, but we were unable to assess the impact of the addition of cannabis extracts. For food product developers, it is critical that we have the ability to quickly evaluate different product attributes; a tool that wasn't available to us until now," said Peter Crooks, Chief Product Innovation Officer, Dosecann. "We will very quickly begin to apply the ability, under this research licence, to conduct organoleptic assessments in order to evaluate the impact of different cannabis extracts on our edible formulations. Having this ability to conduct in-house testing will lead to better tasting products for our consumers, generate additional proprietary knowledge into our approach to flavour development, processing and manufacturing, and support the optimization of the cannabis extracts used in our different edible product segments."
Hugo Alves, CEO of Auxly added: "This is a key license for Auxly's product innovation strategy and our efforts to develop incredible cannabis products that deliver on a consumer promise of quality, safety and efficacy. The incorporation of consumer input and feedback during product development is critical to those efforts and has been demonstrated repeatedly to reduce costs and time to market and increase product acceptance by consumers. Peter and his team at Dosecann now have all of the tools they need to innovate and delight consumers with new and exciting cannabis products, all accurately dosed and manufactured to Dosecann's exacting standards."
Neptune Wellness Solutions Inc. (NASDAQ: NEPT) (TSX: NEPT), a diversified and fully integrated health and wellness company, announced that it has been authorized by Health Canada to sell cannabis products to provinces and territories. This sales license includes edibles, vapes, extracts, and topicals, including beverage products to name a few. This authorization adds to previously held processing license and will expand Neptune's cannabis operations to include proprietary branded products. Additionally, the authorization enhances the capabilities of the Company's white label offerings, providing incremental value and service offerings to its B2B customers.
In addition to the sales license, Neptune's cold storage and added operating space have been approved for operation. The enlarged cold storage and approved space in the Sherbooke facility provide greater capacity to process larger volumes of product and store at low temperature to protect product. The increased storage adds significantly to Neptune's logistic capabilities and provides incremental solutions to the Company's clients.
"The receipt of our sales license is a major milestone for Neptune and significantly expands our cannabis revenue opportunities. We are already advanced in our development of our own brands, and look forward to announcing new branded products. We also see potential for future co-branded opportunities. Additionally, the license enhances our white label business, allowing us to ship direct to provincial customers on behalf of our partners. We plan to further enhance our production capabilities to expand both our branded and white label product solutions and product forms and capture incremental value within the growing Canadian cannabis market," said Michael Cammarata, Chief Executive Officer of Neptune Wellness Solutions. "The sales license, along with our approval to begin operating our expanded space and cold storage significantly increase our capabilities to support our customers, solve the storage limitation inherent among many current and potential cannabis customers and provide significantly higher value to our partners and customers, capturing incremental revenue and growth."
Aurora Cannabis Inc. (NYSE: ACB) (TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, announced yesterday that Co-Founder Terry Booth has retired from his role as Director of the Company, effective June 26, 2020. Mr. Booth was the Chief Executive Officer of Aurora from December 2014 through February 2020 and served on Aurora's Board of Directors since December 2014.
"On behalf of our Board of Directors and management team, I would like to thank Terry for his leadership over the years and for his tenure as a director," said Michael Singer, Executive Chairman and Interim CEO of Aurora. "As one of the original cannabis visionaries, Terry leaves an enviable legacy in the form of Aurora Cannabis. He helped set the table for the Company to lead in Canada and globally, and we continue to execute our plan to do so profitably."
Investor ideas reminds all listeners to read our disclaimers and disclosures on the Investorideas.com website and that this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment.
Learn more about our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp
To hear more Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.
Investorideas.com podcasts are also available on iTunes, Spotify, Google Play Music, Stitcher, Spreaker, YouTube via Spreaker, iHeartradio and Tunein.
Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708
About Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com is a recognized news source publishing third party news, research and original financial content. Learn about investing in stocks and sector trends with our news alerts, articles, podcasts and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy and more. Investor Idea's original branded content includes the following podcasts and columns: Crypto Corner, Play by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and column, Cleantech and Climate Change, Exploring Mining the AI Eye.
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions.
More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.
Follow us on Cannabis Social Media
Download our Mobile App for iPhone and Android
Buy a cannabis guest post on Investorideas.com